I've been accumulating this stock over the last year. Not only will this be approved, but approval opens the doorway for other drugs for other indications. With the platform approved (others are in line), and FDA approved drugs being delivered, the FDA approval process is much shorter for other indications. They just need to prove efficacy and safety. It's really smart of them not to reinvent the wheel, just the delivery system. Latanoprost, which is next in line for cataracts has been used for years. The FDA knows it's efficacy and safety as it's now off patent and being made as generics. An insert every six months sounds a lot better that twice daily ointments.